• 1000
  • 1000

Intellipharmaceutics International Inc. ("IP Int Inc.") and Intellipharmaceutics Corp ("IPC") filed an assignment in bankruptcy on October 31, 2024 and KPMG Inc. was appointed as the trustee-in-bankruptcy (the "Trustee") of the Estates of the Bankrupt by the Official Receiver, subject to affirmation by the creditors of Trustee's appointment or substitution of another Trustee by the creditors.

Intellipharmaceutics International Inc.

The First Meeting of Creditors of Intellipharmaceutics International Inc. will be held by teleconference on the 18th day of November, 2024 at 2:30 PM Eastern Time. Teleconferencing details are as follows:

Phone Conference ID: 791 348 433#, 647-794-1236

Estate Information

Certificate of assignment dated October 31, 2024 [PDF 72 KB]
Notice to Creditors [PDF 3 MB]
Proof of Claim [PDF 109 KB]
Proxy [PDF 36 KB]
Intellipharmaceutics International Inc - Trustee Preliminary Report [PDF 294 KB]

Intellipharmaceutics Corp.

The First Meeting of Creditors of Intellipharmaceutics Corp. will be held by teleconference on the 18th day of November, 2024 at 1:00 PM Eastern Time. Teleconferencing details are as follows:

Phone Conference ID: 678 478 1#, 647-794-1236

Estate Information

Certificate of assignment dated October 31, 2024 [PDF 72 KB]
Notice to Creditors [PDF 6.5 MB]
Proof of Claim [PDF 109 KB]
Proxy [PDF 35 KB]
Intellipharmaceutics Corp - Trustee Preliminary Report [PDF 301 KB]

 

Contact information

intellipharmaceutics@kpmg.ca

Toll free phone number:
(833) 724-2730

Local phone number:
(416) 777-8860

Please be aware that the numbers above are voicemail answering machines only. Please leave a message and a representative of the Trustee will endeavour to get back to you as soon as possible.

Connect with us